(11.ALPHA.,16.BETA.)-11-HYDROXY-2'-METHYL-5'H-PREGNA-1,4-DIENO(17,16-D)OXAZOLE-3,20-DIONE
UNII XAA8C6CK69
Substance Identification & Data
This profile provides standardized clinical and technical data for (11.alpha.,16.beta.)-11-hydroxy-2'-methyl-5'h-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XAA8C6CK69.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1431941-43-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (11.alpha.,16.beta.)-11-hydroxy-2'-methyl-5'h-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.